The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GALNT14 genotype-guided, sorafenib in combination with transarterial chemoembolization in hepatocellular carcinoma: An interim report of a prospective randomized controlled trial.
 
Chau-Ting Yeh
Honoraria - Roche
Research Funding - Janssen
Travel, Accommodations, Expenses - Roche
 
Wei-Chen Lee
No Relationships to Disclose
 
Shi-Ming Lin
No Relationships to Disclose
 
Chih-Lang Lin
No Relationships to Disclose
 
Chao-Wei Hsu
Research Funding - Gilead Sciences; Roche
 
Ting-Jung Wu
No Relationships to Disclose
 
Ming-Chin Yu
No Relationships to Disclose
 
Chien-Fu Hung
No Relationships to Disclose
 
Jeng-Hwei Tseng
No Relationships to Disclose
 
Chen-Chun Lin
No Relationships to Disclose
 
Wei-Ting Chen
No Relationships to Disclose
 
Wei Teng
No Relationships to Disclose
 
Yi-Cheng Chen
Research Funding - Roche
 
Ming-Ling Chang
No Relationships to Disclose